|
MRI News Service:
'AMAG Pharmaceuticals, Inc.' p2 |
|
| Result: Searchterm 'AMAG Pharmaceuticals, Inc.' found in 18 news | | Result Pages | | More Results:  Database (10) |
|
|
 |
 | | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, ...' | | Friday, 5 February 2010 by www.snl.com |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the pricing of an underwritten public offering of 3,600,000 shares of its common stock at a price to the public of $48.25 per share. The number of shares reflects an increase of 600,000 shares ...' | | | Wednesday, 20 January 2010 by www.snl.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian J.G. Pereira, MD, President and CEO, will present an overview of the Company and provide an update on the commercial launch of Feraheme(R) (ferumoxytol) Injection at the 28th Annual ...' | | | Tuesday, 5 January 2010 by www.snl.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Dr. Lesley Russell, Executive Vice President and Chief Medical Officer of Cephalon, has been elected to AMAG's Board of Directors, effective immediately. Additionally, the Company ...' | | | Thursday, 17 December 2009 by www.snl.com | |
|
|
|
| | | ''''The Company commenced the U.S. commercial launch of Feraheme(TM) (ferumoxytol) Injection on July 13, 2009, within two weeks of receipt of FDA approval. The Company reported $3.0 million of total revenues for the third quarter ...' | | | Thursday, 29 October 2009 by www.snl.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report unaudited consolidated financial results for the quarter ended June 30, 2009 after the U.S. financial markets close on July 29, 2009. The announcement will be followed by a ...' | | | Wednesday, 22 July 2009 by www.snl.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Feraheme(TM) (ferumoxytol) Injection is now available for commercial sale in the United States. Feraheme is an intravenous (IV) iron replacement therapy for the treatment of iron deficiency ...' | | | Monday, 13 July 2009 by www.snl.com | |
|
|
|
| | | ''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of ...' | | | Thursday, 30 April 2009 by www.snl.com | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
Do not worry about your difficulties in Mathematics. I can assure you mine
are still greater.
- Albert Einstein |
|
|
News
top
